Recent studies have demonstrated that vimentin is expressed in DTCs of breast cancer patients and tumour cell lines [39,40]; however, there have been no studies in which the expression of both EMT markers (Twist and vimentin) was evaluated in CTCs. This evidence concerns the gene TWIST1 and breast cancer.